Clinical Trial Update: Latency Antibiotics for Previable Rupture Of Membranes Trial [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating latency antibiotics for previable preterm premature rupture of membranes; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Premature Rupture of Membranes

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Preterm Prelabor Rupture of Membranes (PPROM) | Phase 4 | Status: NOT_YET_RECRUITING